The full-year cost of Beizhutifan in 2025 is revealed!

The cost of one year of treatment with Belzutifan is an important consideration for patients, especially when faced with the high medical costs of cancer treatment. Bestifan is a drug targeting hypoxia-inducible factor-2α (HIF-2α). It is mainly used to treat renal cell carcinoma (RCC), central nervous system hemangioblastoma (CNS-HB) and pancreatic neuroendocrine tumors (pNET) related to VHL syndrome. According to the usage and dosage, patients need to take 120 mg orally daily until the disease progresses or unacceptable toxicity occurs.

In the Chinese market, the original drug of Bestivan is usually sold in the Hong Kong version, with a specification of 40mg*90 tablets, and each box sells for about hundreds of thousands of yuan. This means that if calculated based on a daily dosage of 120 mg, patients need to consume one box of medicine every month, so the total cost for one year (12 months) will reach hundreds of thousands of yuan, which is a huge financial burden for many patients.

In comparison, the price of generic drugs in foreign markets, such as Laos and other countries, is relatively low, mainly due to differences in production costs and market pricing strategies. In Laos, the generic version of Bezutivan is also 40mg*90 tablets, and each box may be sold for more than 5,000 yuan. As a result, patients still need one box per month when using generic drugs, and the annual cost is about RMB 60,000 to RMB 70,000. Although the price is much lower than the Hong Kong version of the original drug, patients still need to consider the quality and efficacy of the drug when choosing generic drugs. .

It is worth noting that when choosing a treatment plan, patients not only need to pay attention to the price of the drug, but also fully understand the effect, side effects, and indications of the drug. Although Bestifan has shown good efficacy in clinical trials, it may also be associated with some side effects, such as anemia, fatigue, etc. Therefore, blood indicators need to be regularly monitored during treatment to evaluate the patient's tolerance and treatment effect. This requires maintaining good communication between patients and doctors and adjusting medication plans according to individual circumstances.

Reference materials:https://www.welireg.com/